Literature DB >> 27497357

Evaluation of vascular healing of polymer-free sirolimus-eluting stents in native coronary artery stenosis: a serial follow-up at three and six months with optical coherence tomography imaging.

Pannipa Suwannasom1, Yoshinobu Onuma, Edouard Benit, Olivier Gach, Clemens von Birgelen, Sjoerd H Hofma, Yohei Sotomi, Xu Bo, Yao-Jun Zhang, Runlin Gao, Hector M García-García, Joanna J Wykrzykowska, Robbert J de Winter, Patrick W Serruys.   

Abstract

AIMS: Our aim was to assess vascular response after polymer-free sirolimus-eluting stent (SES) implantation by using an optical coherence tomography (OCT)-derived vascular healing score (HS), quantifying the deficiency of healing. METHODS AND
RESULTS: In a prospective, multicentre, single-arm, open-label study, OCT examinations were performed at three months in 45 patients (47 lesions). Per protocol, 24 lesions which had not reached adequate vascular healing according to study criteria were scheduled for OCT examination at six months. The HS was calculated at two time points. Serial OCT imaging demonstrated that the proportion of covered stent struts increased from a median of 87.1% at three months to 98.6% at six months (p<0.001). The neointimal thickness increased from a median of 82.8 µm to 112.2 µm (p<0.001), whereas the median percentages of malapposed struts were 0.2% and 0.0% at the two respective time points. Neointimal volume obstruction increased from 6.3% to 12.8%, and the HS decreased from a median of 28.1 at three months to 2.4 at six months.
CONCLUSIONS: In patients who had inadequate vascular healing three months after polymer-free SES implantation, serial OCT showed almost complete vascular healing at six months.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27497357     DOI: 10.4244/EIJV12I5A97

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  5 in total

1.  Healing score of the Xinsorb scaffold in the treatment of de novo lesions: 6-month imaging outcomes.

Authors:  Xucheng Lv; Li Shen; Yizhe Wu; Lei Ge; Jiahui Chen; Jiasheng Yin; Rui Wang; Meng Ji; Bin Hong; Junbo Ge
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-28       Impact factor: 2.357

2.  Vulnerable struts with CRE8, Biomatrix and Xience stents assessed with OCT and their correlation with clinical variables at 6-month follow-up: the CREBX-OCT study.

Authors:  Cristina Giglioli; Chiara Formentini; Salvatore Mario Romano; Emanuele Cecchi; Giorgio Jacopo Baldereschi; Daniele Landi; Marco Chiostri; Francesco Prati; Niccolò Marchionni
Journal:  Int J Cardiovasc Imaging       Date:  2019-10-30       Impact factor: 2.357

3.  A Randomized Comparison of the Healing Response Between the Firehawk Stent and the Xience Stent in Patients With ST-Segment Elevation Myocardial Infarction at 6 Months of Follow-Up (TARGET STEMI OCT China Trial): An Optical Coherence Tomography Study.

Authors:  Yuan He; Rutao Wang; Jianzheng Liu; Fei Li; Jiayi Li; Chengxiang Li; Jingyu Zhou; Zhijing Zhao; Wangwei Yang; Fangjun Mou; Jing Wang; Jing Kan; Xiaobo Li; Yan Li; Ming Zheng; Shaoliang Chen; Chao Gao; Ling Tao
Journal:  Front Cardiovasc Med       Date:  2022-06-01

Review 4.  Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy.

Authors:  Aleena Mary Cherian; Shantikumar V Nair; Vijayakumar Maniyal; Deepthy Menon
Journal:  APL Bioeng       Date:  2021-06-01

Review 5.  Endpoint selection for noninferiority percutaneous coronary intervention trials: a methodological description.

Authors:  Matthias Waliszewski; Mark Rosenberg; Harald Rittger; Viktor Breul; Florian Krackhardt
Journal:  Ther Adv Cardiovasc Dis       Date:  2020 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.